Intersect ENT

$0.00 (0.00%) As of 9:59 PM UTC today

Why Robinhood?

You can watch Intersect ENT and buy or sell other stocks, options, and ETFs commission-free!

About XENT

Intersect ENT Inc. (formerly Sinexus) is a medical device company pioneering novel therapies for Ear, Nose, and Throat surgeons to utilize in providing improved treatment for their patients.

CEO
Thomas A. West, MBA
Employees
433
Headquarters
Menlo Park, California
Founded
2003

XENT Key Statistics

Market cap
954.79M
Price-Earnings ratio
—
Dividend yield
—
Average volume
733.84K
High today
—
Low today
—
Open price
—
Volume
0.00
52 Week high
$28.25
52 Week low
$15.92

XENT Earnings

-$1.27
-$0.85
-$0.42
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 5, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure